Cancer Proteome and Biomarkers

Cancer Proteome and Biomarkers

Proteomics technologies are employed in the discovery of novel therapeutic medicines and for early identification and diagnosis of malignancies. With advancements in the science of proteomics and the use of mass spectrometry, breast cancer observation, prognosis, diagnosis, and treatment are now possible.

With the development of proteomics technology, researchers have been able to distinguish between disease and disease-free states linked with breast cancer. Proteins expressed or discovered in serum, plasma, and tumour cells employing novel approaches provide for a better understanding of cancer heterogeneity. Proteomics in Breast Cancer Proteomics in Skin Cancer Proteomics in Lung Cancer Proteomics in Ovarian Cancer Proteomics in Colorectal Cancer.

 

  • Protein expression services and market analysis
  • Recombinant protein drugs

Related Conference of Cancer Proteome and Biomarkers

March 17-18, 2025

54th World Congress on Microbiology

Berlin, Germany
July 28-29, 2025

17th International Virology Summit

Paris, France
August 25-26, 2025

6th International Conference on Molecular Microbiology

Singapore City, Singapore
September 22-23, 2025

13th World Congress and Expo on Applied Microbiology

Dubai, UAE

Cancer Proteome and Biomarkers Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in